Does EPLERENONE Cause Activated partial thromboplastin time prolonged? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Activated partial thromboplastin time prolonged have been filed in association with EPLERENONE (Inspra). This represents 0.4% of all adverse event reports for EPLERENONE.
13
Reports of Activated partial thromboplastin time prolonged with EPLERENONE
0.4%
of all EPLERENONE reports
0
Deaths
13
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From EPLERENONE?
Of the 13 reports, 13 (100.0%) required hospitalization.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPLERENONE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does EPLERENONE Cause?
Acute kidney injury (570)
Hypotension (398)
Dyspnoea (395)
Cardiac failure (338)
Oedema peripheral (268)
Dizziness (248)
Hyperkalaemia (248)
Drug ineffective (244)
Fatigue (202)
Off label use (188)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which EPLERENONE Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
EPLERENONE vs EPLONTERSEN
EPLERENONE vs EPOETIN ALFA-EPBX
EPLERENONE vs EPOGEN
EPLERENONE vs EPOPROSTENOL
EPLERENONE vs EPTIFIBATIDE